Cited by 1,425Brain Metastases and TreatmentManagement of metastatic bone diseaseCancer survivorship and care

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

Open access

Sperduto, Paul W., Kased, Norbert, Roberge, David, Xu, Zhiyuan, Shanley, Ryan, Luo, Xianghua, Sneed, Penny K., Chao, Samuel T., Weil, Robert J., Suh, John, Bhatt, Amit, Jensen, Ashley W., Brown, Paul D., Shih, Helen A., Kirkpatrick, John, Gaspar, Laurie E., Fiveash, John B., Chiang, Veronica, Knisely, Jonathan P.S., Sperduto, Christina Maria, Lin, Nancy, Mehta, Minesh·2012·Journal of Clinical Oncology

DOI 10.1200/jco.2011.38.0527PMC PMC3269967

Open this paper in CoChat — free account

Abstract

PURPOSE: Our group has previously published the Graded Prognostic Assessment (GPA), a prognostic index for patients with brain metastases. Updates have been published with refinements to create diagnosis-specific Graded Prognostic Assessment indices. The purpose of this report is to present the updated diagnosis-specific GPA indices in a single, unified, user-friendly report to allow ease of access and use by treating physicians. METHODS: A multi-institutional retrospective (1985 to 2007) database of 3,940 patients with newly diagnosed brain metastases underwent univariate and multivariate analyses of prognostic factors associated with outcomes by primary site and treatment. Significant prognostic factors were used to define the diagnosis-specific GPA prognostic indices. A GPA of 4.0 correlates with the best prognosis, whereas a GPA of 0.0 corresponds with the worst prognosis. RESULTS: Significant prognostic factors varied by diagnosis. For lung cancer, prognostic factors were Karnofsky performance score, age, presence of extracranial metastases, and number of brain metastases, confirming the original Lung-GPA. For melanoma and renal cell cancer, prognostic factors were Karnofsky performance score and the number of brain metastases. For breast cancer, prognostic factors were tumor subtype, Karnofsky performance score, and age. For GI cancer, the only prognostic factor was the Karnofsky performance score. The median survival times by GPA score and diagnosis were determined. CONCLUSION: Prognostic factors for patients with brain metastases vary by diagnosis, and for each diagnosis, a robust separation into different GPA scores was discerned, implying considerable heterogeneity in outcome, even within a single tumor type. In summary, these indices and related worksheet provide an accurate and facile diagnosis-specific tool to estimate survival, potentially select appropriate treatment, and stratify clinical trials for patients with brain metastases.

Integrity signals

Registry

Crossref · 10.1200/jco.2011.38.0527

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,858
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 21,030
Cancer Statistics, 2008
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184
Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials
Gaspar, L. E., Scott, C., Rotman, M., Asbell, S. O., Phillips, T. L., Wasserman, T. H., McKenna, W. G., & Byhardt, R. W. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00619-0 · Cited by 2,548
Self-citation
A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database
Sperduto, P. W., Berkey, B. A., Gaspar, L. E., Mehta, M. P., & Curran, W. J. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.074 · Cited by 1,031
Self-citation
An Introduction to Recursive Partitioning Using the RPART Routines
Therneau, T. M., & Atkinson, E. J. (2015) · Cited by 1,006
Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients
Sperduto, P. W., Chao, S. T., Sneed, P. K., Luo, X., Suh, J. H., Roberge, D., Bhatt, A. K., Jensen, A. W., Brown, P. D., Shih, H. A., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.08.025 · Cited by 987
Self-citation
Intracerebral metastases in solid-tumor patients: Natural history and results of treatment
Zimm, S., Wampler, G. L., Stablein, D., Hazra, T. A., & Young, H. F. (1981) · Cancer · doi:10.1002/1097-0142(19810715)48:2 · Cited by 597
Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases
Gaspar, L. E., Scott, C., Murray, K., & Curran, W. J. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00547-2 · Cited by 531
Self-citation
Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases
Sperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J. H., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.02.027 · Cited by 367
Self-citation

Show all 21 references

Research works printed but not linked: 1

Therneau TM, 1997, Technical Report 61

Sorted by citations

Items 501–600 of 1,000

Extended Survival in Patients With Non–Small-Cell Lung Cancer–Associated Brain Metastases in the Modern Era
Berger, A., Mullen, R., Bernstein, K., Alzate, J. D., Silverman, J. S., Sulman, E. P., Donahue, B. R., Chachoua, A., Shum, E., Velcheti, V., et al. (2023) · Neurosurgery · doi:10.1227/neu.0000000000002372 · Cited by 20
Outcome assessment of intraoperative radiotherapy for brain metastases: results of a prospective observational study with comparative matched-pair analysis
Layer, J. P., Hamed, M., Potthoff, A., Dejonckheere, C. S., Layer, K., Sarria, G. R., Scafa, D., Koch, D., Köksal, M. A., Kugel, F., et al. (2023) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04380-w · Cited by 20
Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers
Brozos-Vázquez, E., Rodríguez-López, C., Cortegoso-Mosquera, A., López-Landrove, S., Muinelo‐Romay, L., García, J., López‐López, R., & León‐Mateos, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1221113 · Cited by 20
Systemic treatment after whole-brain radiotherapy may improve survival in RPA class II/III breast cancer patients with brain metastasis
Zhang, Q., Chen, J., 俞晓立, Ma, J., Cai, G., 杨兆知, Cao, L., Chen, X., 郭小毛, & Chen, J. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1169-4 · Cited by 20
Quelle place pour l’irradiation panencéphalique avec épargne des hippocampes ?
Truc, G., Martin, E., Mirjolet, C., Chamois, J., Petitfils, A., & Créhange, G. (2013) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2013.06.042 · Cited by 20
Breast cancer subtype as a predictor for outcomes and control in the setting of brain metastases treated with stereotactic radiosurgery
Grubb, C. S., Jani, A., Wu, C., Saad, S., Qureshi, Y. H., Nanda, T., Yaeh, A. M., Rozenblat, T., Sisti, M. B., Bruce, J. N., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-2014-8 · Cited by 20
Multimodality treatment of brain metastases from renal cell carcinoma in the era of targeted therapy
Bassanelli, M., Viterbo, A., Roberto, M., Giacinti, S., Staddon, A., Aschelter, A. M., D’Antonio, C., & Marchetti, P. (2016) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834016659825 · Cited by 20
Estimating prognosis at the time of repeat whole brain radiation therapy for multiple brain metastases: The reirradiation score
Logie, N., Jimenez, R., Pulenzas, N., Linden, K. C., Ciafone, D., Ghosh, S., Xu, Y., Lefresne, S., Wong, E., Son, C. H., et al. (2017) · Advances in Radiation Oncology · doi:10.1016/j.adro.2017.05.010 · Cited by 20
Self-citation
Melanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy
Fang, P., Boehling, N. S., Koay, E. J., Bucheit, A. D., Jakob, J. A., Settle, S. H., Brown, P. D., Davies, M. A., & Sulman, E. P. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2695-2 · Cited by 20
Self-citation
Natural history, clinical course and predictors of interval time from initial diagnosis to development of subsequent NSCLC brain metastases
Smith, D. R., Bian, Y., Wu, C., Saraf, A., Tai, C.-H., Nanda, T., Yaeh, A. M., Lapa, M. E., Andrews, J. I. S., Cheng, S. K., et al. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03149-4 · Cited by 20
WBRT for brain metastases from non-small cell lung cancer: for whom and when?—Contemporary point of view
Sas-Korczyńska, B., & Rucińska, M. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-2019-rbmlc-06 · Cited by 20
Hypofractionated frameless gamma knife radiosurgery for large metastatic brain tumors
Samancı, Y., Şişman, U., Altıntaş, A., Sarıoğlu, S., Sharifi, S., Atasoy, A. İ., Bölükbaşı, Y., & Peker, S. (2021) · Clinical & Experimental Metastasis · doi:10.1007/s10585-020-10068-6 · Cited by 20
Nocardia farcinica cerebral abscess: A systematic review of treatment strategies
Beucler, N., Farah, K., Choucha, A., Meyer, M., Fuentes, S., Seng, P., & Dufour, H. (2021) · Neurochirurgie · doi:10.1016/j.neuchi.2021.04.022 · Cited by 20
Additional prognostic role of EGFR activating mutations in lung adenocarcinoma patients with brain metastasis: Integrating with lung specific GPA score
Lee, D.-W., Shin, D., Kim, J. W., Keam, B., Kim, T. M., Kim, H. J., Kim, D., Wu, H.-G., Paek, S. H., Kim, Y. W., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.10.001 · Cited by 20
Radiation Therapy for the Management of Brain Metastases
Garrett, M. D., Wu, C., Yanagihara, T. K., Jani, A., & Wang, T. J. C. (2016) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000296 · Cited by 19
Performance sensitivity analysis of brain metastasis stereotactic radiosurgery outcome prediction using MRI radiomics
DeVries, D. A., Lagerwaard, F. J., Zindler, J. D., Yeung, T. P. C., Rodrigues, G., Hajdok, G., & Ward, A. D. (2022) · Scientific Reports · doi:10.1038/s41598-022-25389-7 · Cited by 19
Local Control and Survival Outcomes After Stereotactic Radiosurgery for Brain Metastases From Gastrointestinal Primaries: An International Multicenter Analysis
Singh, R. B., Bowden, G. N., Mathieu, D., Perlow, H. K., Palmer, J. D., Elhamdani, S., Shepard, M. J., Liang, Y., Nabeel, A. M., Reda, W. A. H., et al. (2023) · Neurosurgery · doi:10.1227/neu.0000000000002456 · Cited by 19
Self-citation
Local control strategies for management of NSCLC with oligoprogressive disease
Mavrikios, A., Remón, J., Quevrin, C., Mercier, O. M., Tselikas, L., Botticella, A., Nicolas, E., Deutsch, É., Besse, B., Planchard, D., et al. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102621 · Cited by 19
Role of stereotactic radiosurgery in patients with more than four brain metastases
Jairam, V., Chiang, V., Yu, J. B., & Knisely, J. P. S. (2013) · CNS Oncology · doi:10.2217/cns.13.4 · Cited by 19
Self-citation
Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC)
Putora, P. M., Ess, S. M., Panje, C. M., Hundsberger, T., van Leyen, K., Plaßwilm, L., & Früh, M. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9699-0 · Cited by 19
Stereotactic radiosurgery for 318 brain metastases in a single Australian centre: The impact of histology and other factors
Sia, J., Paul, E. M., Dally, M. J., & Ruben, J. (2014) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2014.07.019 · Cited by 19
Clinical Outcome of Stereotactic Radiosurgery for Central Nervous System Metastases From Renal Cell Carcinoma
Seastone, D. J., Elson, P. J., Garcia, J., Chao, S. T., Suh, J. H., Angelov, L., & Rini, B. I. (2013) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2013.10.001 · Cited by 19
Self-citation
Non-coding RNAs in cancer brain metastasis
Watabe, K. (2016) · Frontiers in Bioscience-Scholar · doi:10.2741/s457 · Cited by 19
Evaluation of Dose-Staged Gamma Knife Radiosurgical Treatment Method for High-Risk Brain Metastases
Frischer, J. M., Fraller, A., Mallouhi, A., Vogl, U. M., Baier, F., Ertl, A., Preusser, M., Knosp, E., Kitz, K., & Gatterbauer, B. (2016) · World Neurosurgery · doi:10.1016/j.wneu.2016.07.038 · Cited by 19
Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices
Bernhardt, D., König, L., Aufderstrasse, S., Krisam, J., Hoerner‐Rieber, J., Adeberg, S., Bozorgmehr, F., Shafie, R. A. E., Lang, K., Kappes, J., et al. (2017) · Clinical Lung Cancer · doi:10.1016/j.cllc.2017.12.004 · Cited by 19
Surgical Treatment of the Septuagenarian Patients Suffering From Brain Metastases: A Large Retrospective Observational Analytic Cohort-Comparison Study
Frati, A., Pesce, A., Palmieri, M., Çelniku, M., Raco, A., & Salvati, M. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.03.034 · Cited by 19
Novel graded prognostic assessment for colorectal cancer patients with brain metastases
Kim, B. H., Park, H. J., Kim, K., Han, S., Kim, T., Jeong, S., Park, K. J., & Chie, E. K. (2018) · International Journal of Clinical Oncology · doi:10.1007/s10147-018-1329-9 · Cited by 19
Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in Mice
Rothwell, W. T., Bell, P. L., Richman, L. K., Limberis, M. P., Tretiakova, A. P., Li, M., & Wilson, J. M. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0363 · Cited by 19
Bases référentielles de la radiothérapie en conditions stéréotaxiques pour les tumeurs ou métastases bronchopulmonaires, hépatiques, prostatiques, des voies aérodigestives supérieures, cérébrales et osseuses
Barillot, I., Antoni, D., Bellec, J., Biau, J., Giraud, P., Jenny, C., Lacornerie, T., Lisbona, A., Marchesi, V., Mornex, F., et al. (2018) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2018.08.001 · Cited by 19
Metastatic melanoma: Surgical treatment of brain metastases – Analysis of 110 patients
McHugh, F., Kow, C. Y., Falkov, A., Heppner, P. A., Law, A. J. J., Bok, A. P. L., & Schweder, P. M. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.12.063 · Cited by 19
Clinical Outcomes in Patients with Renal Cell Carcinoma Metastases to the Choroid Plexus
Crisman, C., Patel, A., Winston, G. M., Brennan, C., Tabar, V. S., & Moss, N. S. (2020) · World Neurosurgery · doi:10.1016/j.wneu.2020.03.125 · Cited by 19
Outcomes of Treatment for Melanoma Brain Metastases
Janavicius, M., Lachej, N., Anglickienė, G., Vincerževskienė, I., & Brasiūnienė, B. (2020) · Journal of Skin Cancer · doi:10.1155/2020/7520924 · Cited by 20
Update on Brain Tumors: New Developments in Neuro‐oncologic Diagnosis and Treatment, and Impact on Rehabilitation Strategies
Shahpar, S., Mhatre, P. V., & Huang, M. E. (2015) · PM&R · doi:10.1016/j.pmrj.2015.10.012 · Cited by 19
Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG)
Christodoulou, C., Kalogera‐Fountzila, A., Karavasilis, V., Kouvatseas, G., Papandreou, C. N., Samantas, E., Varaki, K., Papadopoulos, G., Bobos, M., Rallis, G., et al. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2548-z · Cited by 19
Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastases
Bernatz, S., Ilina, E. I., Devraj, K., Harter, P. N., Mueller, K. M., Kleber, S., Braun, Y., Penski, C., Renner, C., Halder, R., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1427-1 · Cited by 19
Prognostic factors for survival in colorectal cancer patients with brain metastases undergoing whole brain radiotherapy: multicenter retrospective study
Koo, T., Kim, K., Park, H. J., Han, S., Kim, T., Jeong, S., Park, K. J., & Chie, E. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-61354-y · Cited by 19
Better treatments needed for breast cancer brain metastases
Lin, N. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00477-5 · Cited by 18
Self-citation
Radiotherapy and Immunotherapy in Melanoma Brain Metastases
Anvari, A., Sasanpour, P., & Kheradmardi, M. R. (2021) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2021.11.001 · Cited by 20
Genomic predictors of radiation response: recent progress towards personalized radiotherapy for brain metastases
Harary, P. M., Rajaram, S., Chen, M. S., Hori, Y. S., Park, D. J., & Chang, S. D. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02270-2 · Cited by 20
CAVEOLIN-1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance, irrespective of tumor histotype
Duregon, E., Senetta, R., Pittaro, A., di Cantogno, L. V., Stella, G. M., Blasi, P. D., Zorzetto, M., Mantovani, C., Papotti, M. G., & Cassoni, P. (2015) · Oncotarget · doi:10.18632/oncotarget.4988 · Cited by 18
Immunotherapy and targeted therapy in brain metastases: emerging options in precision medicine
Lazaro, T. T., & Brastianos, P. K. (2017) · CNS Oncology · doi:10.2217/cns-2016-0038 · Cited by 18
Brain volume reduction after whole-brain radiotherapy: quantification and prognostic relevance
Hoffmann, C., Distel, L. V., Knippen, S., Gryc, T., Schmidt, M. A., Fietkau, R., & Putz, F. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox150 · Cited by 18
Analysis of survival outcomes based on molecular subtypes in breast cancer brain metastases: A single institutional cohort
Jeon, W., Jang, B., Jeon, S. H., Kim, J. H., Kim, Y. J., Kim, S. H., Kim, C., Han, J. H., & Kim, I. A. (2018) · The Breast Journal · doi:10.1111/tbj.13111 · Cited by 19
The Efficacy of Upfront Intracranial Radiation with TKI Compared to TKI Alone in the NSCLC Patients Harboring EGFR Mutation and Brain Metastases
Wang, C., Lu, X. J., Zhou, Z., Wang, J., Hui, Z., Liang, J., Feng, Q., Chen, D., Xiao, Z., Lv, J., et al. (2019) · Journal of Cancer · doi:10.7150/jca.30131 · Cited by 18
Efficacy of EGFR‐TKIs with or without upfront brain radiotherapy for EGFR‐mutant NSCLC patients with central nervous system metastases
Saida, Y., Watanabe, S., Abe, T., Shoji, S., Nozaki, K., Ichikawa, K., Kondo, R., Koyama, K., Miura, S., Tanaka, H., et al. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.13189 · Cited by 18
Developing Machine Learning Algorithms for the Prediction of Early Death in Elderly Cancer Patients: Usability Study
Sena, G. R., Lima, T. P., de Mello, M. J. G., Thuler, L. C. S., & Lima, J. T. D. O. (2019) · JMIR Cancer · doi:10.2196/12163 · Cited by 18
Insights into brain metastasis: Recent advances in circulating tumor cell research
Klotz, R. V., & Yu, M. (2020) · Cancer Reports · doi:10.1002/cnr2.1239 · Cited by 18
Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancer
Shafie, R. A. E., Seidensaal, K., Bozorgmehr, F., Kazdal, D. N., Eichkorn, T., Elshiaty, M., Weber, D., Allgäuer, M., König, L., Lang, K., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100161 · Cited by 18
Review of the diagnosis and treatment of brain metastases
Narita, Y., Sato, S., & Kayama, T. (2021) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyab182 · Cited by 18
Frequent overexpression of ErbB – receptor family members in brain metastases of non‐small cell lung cancer patients
Berghoff, A. S., Magerle, M., Ilhan‐Mutlu, A., Dinhof, C., Widhalm, G., Dieckman, K., Marosi, C., Wöehrer, A., Hackl, M., Zöchbauer‐Müller, S., et al. (2013) · Apmis · doi:10.1111/apm.12063 · Cited by 18
Utility of graded prognostic assessment in evaluation of patients with brainstem metastases treated with radiosurgery
Joshi, R., Johnson, M. D., Maitz, A. H., Marvin, K. S., Olson, R. E., & Grills, I. S. (2016) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2016.05.001 · Cited by 18
Trends in peri-operative performance status following resection of high grade glioma and brain metastases: The impact on survival
Patel, C. K., Vemaraju, R., Glasbey, J. C., Shires, J., Northmore, T., Zaben, M., & Hayhurst, C. (2017) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2017.11.016 · Cited by 18
Pre-stereotactic radiosurgery neutrophil-to-lymphocyte ratio is a predictor of the prognosis for brain metastases
Zhang, L., Hu, Y., Chen, W., Tian, Y., Xie, Y., & Chen, J. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03477-w · Cited by 18
Perioperative imaging in patients treated with resection of brain metastases: a survey by the European Association of Neuro-Oncology (EANO) Youngsters committee
Kiesel, B., Thomé, C. M., Weiß, T., Jakola, A. S., Darlix, A., Pellerino, A., Furtner, J., Kerschbaumer, J., Freyschlag, C. F., Wick, W., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-06897-z · Cited by 18
Nanomedicines in the Treatment of Brain Tumors
Fisusi, F. A., Schätzlein, A. G., & Uchegbu, I. F. (2018) · Nanomedicine · doi:10.2217/nnm-2017-0378 · Cited by 18
Application of EGFR-TKIs in brain tumors, a breakthrough in future?
Feng, S., Liu, H., Yun, C., Zhu, W. Z., & Pan, Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06448-9 · Cited by 19
Palliative Radiotherapy and Oncology Nursing
McMenamin, E. M., Ross, N., & Jones, J. (2014) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2014.08.006 · Cited by 17
Treatment Modalities for Advanced ALK -Rearranged Non-Small-Cell Lung Cancer
Sullivan, I., & Planchard, D. (2016) · Future Oncology · doi:10.2217/fon.16.15 · Cited by 17
Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases
Lin, X., Lü, T., Deng, H., Liu, C., Yang, Y., Chen, T., Qin, Y., Xie, X., Xie, Z., Liu, M., et al. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10660-0 · Cited by 17
Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non–small cell lung cancer
Nayak, L., DeAngelis, L. M., Robins, H. I., Govindan, R., Gadgeel, S. M., Kelly, K. L., Rigas, J. R., Peereboom, D. M., Rosenfeld, S. S., Muzikansky, A., et al. (2015) · Cancer · doi:10.1002/cncr.29636 · Cited by 17
Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma
Lim, S., Lee, S. H., Lim, J. Y., Park, J. S., Seong, J. S., Chang, W. S., Han, K., & Choi, H. J. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1546-7 · Cited by 17
BRAF Mutation Is Associated with Improved Local Control of Melanoma Brain Metastases Treated with Gamma Knife Radiosurgery
Gallaher, I. S., Watanabe, Y., DeFor, T. E., Dusenbery, K. E., Lee, C. K. K., Hunt, M. A., Lin, H.-Y., & Yuan, J. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00107 · Cited by 17
The evolving clinical management of cerebral metastases
Sinha, R., Sage, W., & Watts, C. (2016) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2016.10.006 · Cited by 17
Are immune checkpoint blockade monoclonal antibodies active against CNS metastases from NSCLC?—current evidence and future perspectives
O'Kane, G. M., & Leighl, N. B. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.09.05 · Cited by 18
Management of breast cancer brain metastases: Focus on human epidermal growth factor receptor 2‐positive breast cancer
Yuan, P., & Gao, S. (2017) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2017.01.004 · Cited by 17
Comparing survival predicted by the diagnosis-specific Graded Prognostic Assessment (DS-GPA) to actual survival in patients with 1–10 brain metastases treated with stereotactic radiosurgery
Nagtegaal, S., Claes, A., Suijkerbuijk, K. P. M., Schramel, F. M. N. H., Snijders, T. J., & Verhoeff, J. J. C. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.06.033 · Cited by 17
Immune Checkpoint Inhibitors with or without Radiotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Systematic Review and Meta-Analysis
Kim, D., Kim, P. H., Suh, C. H., Kim, K. W., & Kim, H. S. (2020) · Diagnostics · doi:10.3390/diagnostics10121098 · Cited by 17
Efficacy and Safety of a Second Course of Stereotactic Radiation Therapy for Locally Recurrent Brain Metastases: A Systematic Review
Lucia, F., Touati, R., Crainic, N., Dissaux, G., Pradier, O., Bourbonne, V., & Schick, U. (2021) · Cancers · doi:10.3390/cancers13194929 · Cited by 17
Memantine in the Prevention of Radiation-Induced Brain Damage: A Narrative Review
Scampoli, C., Cammelli, S., Galietta, E., SIEPE, G., Buwenge, M., Macchia, G., Deodato, F., Cilla, S., Strigari, L., Chiesa, S., et al. (2022) · Cancers · doi:10.3390/cancers14112736 · Cited by 17
Brain metastasis from melanoma: the prognostic value of varying sites of extracranial disease
Bates, J. E., Youn, P., Usuki, K. Y., Walter, K. A., Huggins, C. F., Okunieff, P. G., & Milano, M. T. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1932-9 · Cited by 17
The emerging role of advanced neuroimaging techniques for brain metastases.
Nowosielski, M., & Radbruch, A. (2015) · PubMed · doi:10.3978/j.issn.2304-3865.2015.05.04 · Cited by 17
Prognostic factors for patients with brain metastasis from gynecological cancer: a significance of treatment-free interval of more than 6 months
Takeshita, S., Todo, Y., Furuta, Y., Okamoto, K., Minobe, S., Yamashiro, K., & Kato, H. (2017) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyx047 · Cited by 17
Prognostic Importance of Cumulative Intracranial Tumor Volume in Patients with Gastrointestinal Brain Metastasis Treated with Stereotactic Radiosurgery
Joshi, R. S., Hirshman, B. R., Ali, M. A., Alattar, A. A., Carroll, K. T., Nagano, O., Aiyama, H., Serizawa, T., Yamamoto, M., & Chen, C. C. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.09.209 · Cited by 17
Brain metastasis burden and management in patients with small cell lung cancer in Canada: a retrospective, population-based cohort study
Gaebe, K., Erickson, A. W., Chen, S., Menjak, I. B., Lok, B. H., Sahgal, A., Chan, K., & Das, S. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102871 · Cited by 16
Strategies to target drugs to gliomas and CNS metastases of solid tumors
Kerklaan, B. M., van Tellingen, O., Huitema, A. D. R., Beijnen, J. H., Boogerd, W. J., Schellens, J. H. M., & Brandsma, D. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7919-9 · Cited by 16
The TNM 8 M1b and M1c classification for non-small cell lung cancer in a cohort of patients with brain metastases
Nieder, C., Hintz, M., Oehlke, O., Bilger, A., & Grosu, A. (2017) · Clinical & Translational Oncology · doi:10.1007/s12094-017-1651-0 · Cited by 16
Novel Opportunities to Use Radiation Therapy with Immune Checkpoint Inhibitors for Melanoma Management
Ahmed, K. A., Kim, S., & Harrison, L. B. (2017) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2017.01.007 · Cited by 16
The Role of Adhesion Molecules and Extracellular Vesicles in an In Vitro Model of the Blood–Brain Barrier for Metastatic Disease
Vasco, C., Rizzo, A., Cordiglieri, C., Corsini, E., Maderna, E., Ciusani, E., & Salmaggi, A. (2023) · Cancers · doi:10.3390/cancers15113045 · Cited by 18
Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomes
Dejonckheere, C. S., Layer, J. P., Hamed, M., Layer, K., Glasmacher, A. R., Friker, L. L., Potthoff, A., Zeyen, T., Scafa, D., Koch, D., et al. (2023) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04464-7 · Cited by 16
Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches
Lukas, R. V., Lesniak, M. S., & Salgia, R. (2014) · CNS Oncology · doi:10.2217/cns.13.66 · Cited by 16
Radiation-induced brain damage, impact of Michael Robbins’ work and the need for predictive biomarkers
Prasanna, P. G. S., Ahmed, M. M., Stone, H. B., Vikram, B., Mehta, M. P., & Coleman, C. N. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.925607 · Cited by 16
Self-citation
New insights and emerging therapies for breast cancer brain metastases.
Lim, E., & Lin, N. (2012) · PubMed · Cited by 16
Self-citation
Dynamic contrast-enhanced MR imaging pharmacokinetic parameters as predictors of treatment response of brain metastases in patients with lung cancer
Kuchcinski, G., Rhun, É. L., Cortot, A. B., Drumez, É., Duhal, R., Lalisse, M., Dumont, J., Lopes, R., Pruvo, J., Leclerc, X., et al. (2017) · European Radiology · doi:10.1007/s00330-017-4756-5 · Cited by 16
Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA)
Patrikidou, A., Chaigneau, L., Isambert, N., Kitikidou, K., Shanley, R., Ray-Coquard, I. L., Valentin, T., Malivoir, B., Laigre, M., Bay, J., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-6548-6 · Cited by 16
Self-citation
Epigenetic Role of Histone Lysine Methyltransferase and Demethylase on the Expression of Transcription Factors Associated with the Epithelial-to-Mesenchymal Transition of Lung Adenocarcinoma Metastasis to the Brain
Lee, Y. M., Kim, S. H., Kim, M. S., Kim, D. C., Lee, E. H., Lee, J. S., Lee, S. C., & Kim, Y. Z. (2020) · Cancers · doi:10.3390/cancers12123632 · Cited by 16
External Validation of the Bone Metastases Ensemble Trees for Survival (BMETS) Machine Learning Model to Predict Survival in Patients With Symptomatic Bone Metastases
Elledge, C. R., LaVigne, A. W., Fiksel, J., Wright, J. L., McNutt, T., Kleinberg, L. R., Hu, C., Smith, T. J., Zeger, S. L., DeWeese, T. L., et al. (2021) · JCO Clinical Cancer Informatics · doi:10.1200/cci.20.00128 · Cited by 16
Inferior outcome of bone metastasis in non-small-cell-lung-cancer patients treated with epidermal growth factor receptor inhibitors
Chen, Y., Wang, P., Fu, Y., Li, Q., Tian, J., Liu, T., Lin, Z., & Ding, Z. (2021) · Journal of bone oncology · doi:10.1016/j.jbo.2021.100369 · Cited by 16
Repeat stereotactic radiosurgery for locally recurrent brain metastases previously treated with stereotactic radiosurgery: A systematic review and meta-analysis of efficacy and safety.
Singh, R. B., Didwania, P., Lehrer, E. J., Palmer, J. D., Trifiletti, D. M., & Sheehan, J. P. (2022) · PubMed Central · Cited by 16
A Statistical Comparison of Prognostic Index Systems for Brain Metastases after Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy
Rodrigues, G., Gonzalez-Maldonado, S., Bauman, G. S., Senan, S., & Lagerwaard, F. J. (2012) · Clinical Oncology · doi:10.1016/j.clon.2012.11.006 · Cited by 16
Whole brain radiotherapy in patients with NSCLC and brain metastases
Pechoux, C. L., Dhermain, F. G., & Besse, B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31391-5 · Cited by 16
Gait Speed and Survival in Patients With Brain Metastases
Dulaney, C. R., McDonald, A. M., Wallace, A. S., & Fiveash, J. B. (2017) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2017.03.013 · Cited by 16
Self-citation
Retrospective study of 229 surgically treated patients with brain metastases: Prognostic factors, outcome and comparison of recursive partitioning analysis and diagnosis-specific graded prognostic assessment
Pojskić, M., Bopp, M. H. A., Schymalla, M. M., Nimsky, C., & Carl, B. (2017) · Surgical Neurology International · doi:10.4103/sni.sni_228_17 · Cited by 16
Local control of melanoma brain metastases treated with stereotactic radiosurgery.
Bagshaw, H. P., Ly, D., Suneja, G., Jensen, R. L., & Shrieve, D. C. (2016) · Europe PMC (PubMed Central) · Cited by 16
Radiosurgery with flattening-filter-free techniques in the treatment of brain metastases
Rieber, J., Tonndorf‐Martini, E., Schramm, O., Rhein, B., Stefanowicz, S., Kappes, J., Hoffmann, H., Lindel, K., Debus, J., & Rieken, S. (2016) · Strahlentherapie und Onkologie · doi:10.1007/s00066-016-1012-x · Cited by 17
Impact of Tumour Segmentation Accuracy on Efficacy of Quantitative MRI Biomarkers of Radiotherapy Outcome in Brain Metastasis
Jalalifar, S. A., Soliman, H., Sahgal, A., & Sadeghi-Naini, A. (2022) · Cancers · doi:10.3390/cancers14205133 · Cited by 15
Tertiary Lymphoid Structures in Brain Metastases of Lung Cancer: Prognostic Significance and Correlation With Clinical Outcomes
Nohira, S., Kuramitsu, S., OHNO, M., Fujita, M., Yamashita, K., NAGASAKA, T., Haimoto, S., Sakakura, N., Matsushita, H., & SAITO, R. (2024) · Anticancer Research · doi:10.21873/anticanres.17184 · Cited by 15
Impact of systemic treatment on survival after whole brain radiotherapy in patients with brain metastases
Nieder, C., Marienhagen, K., Dalhaug, A., Aandahl, G., Haukland, E. C., & Pawinski, A. (2014) · Medical Oncology · doi:10.1007/s12032-014-0927-2 · Cited by 15
Radiothérapie encéphalique en totalité des métastases cérébrales : intérêts et controverses dans le cadre d’un référentiel
Noël, G., Tallet, A. R., Truc, G., Bernier, V., Feuvret, L., Assouline, A., Antoni, D., Verrelle, P., Mazeron, J. J., Mornex, F., et al. (2015) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2014.12.004 · Cited by 15
Preventing Discontinuation of Radiation Therapy: Predictive Factors to Improve Patient Selection for Palliative Treatment
Puckett, L. L., Luitweiler, E., Potters, L., & Teckie, S. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2017.021220 · Cited by 15
A New Diagnosis-Specific Survival Score for Patients to be Irradiated for Brain Metastases from Non-small Cell Lung Cancer
Rades, D., Hansen, H. C., Schild, S. E., & Janssen, S. (2019) · Lung · doi:10.1007/s00408-019-00223-6 · Cited by 15

Authors: Sperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J., Bhatt, A., Jensen, A. W., Brown, P. D., Shih, H. A., Kirkpatrick, J., Gaspar, L. E., Fiveash, J. B., Chiang, V., Knisely, J. P. S., Sperduto, C. M., Lin, N., & Mehta, M.
Affiliations: University of Minnesota (US)
University of California, San Francisco (US)
McGill University (CA)
Cleveland Clinic (US)
Author affiliations appear at the end of this article.
Mayo Clinic (US)
Harvard University (US)
Duke University (US)
University of Colorado Denver (US)
University of Alabama at Birmingham (US)
Yale University (US)
Hofstra University (US)
Dartmouth College (US)
Northwestern University (US)
ORCID: Sperduto, Paul W.
Kased, Norbert
Roberge, David
Xu, Zhiyuan
Shanley, Ryan
Luo, Xianghua
Sneed, Penny K.
Chao, Samuel T.
Weil, Robert J.
Suh, John
Bhatt, Amit
Brown, Paul D.
Shih, Helen A.
Kirkpatrick, John
Fiveash, John B.
Chiang, Veronica
Knisely, Jonathan P.S.
Mehta, Minesh
Venue: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Published: 2012-02-01
Volume: 30
Issue: 4
Pages: 419-425
ISSN: 0732-183X (ISSN-L)
1527-7755
DOI: 10.1200/jco.2011.38.0527
PMC: PMC3269967
OpenAlex: W1974820090
Cited by: 1,425
References: 21
Citations by year: 2026: 41 · 2025: 57 · 2024: 88 · 2023: 112 · 2022: 103 · 2021: 113 · 2020: 146 · 2019: 117 · 2018: 131 · 2017: 134 · 2016: 115 · 2015: 94 · 2014: 68 · 2013: 62 · 2012: 38
FWCI: 45.80
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Journal of Clinical Oncology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (P30CA-77598, P30CA077598)
Topics: Health Sciences › Medicine › Oncology › Brain Metastases and Treatment
Health Sciences › Medicine › Surgery › Management of metastatic bone disease
Health Sciences › Medicine › Oncology › Cancer survivorship and care
Keywords: brain metastases, Graded Prognostic Assessment, prognosis, survival estimation, prognostic factors, lung cancer, melanoma, renal cell carcinoma, breast cancer, gastrointestinal cancer, Karnofsky performance status, extracranial metastases, number of brain metastases, clinical trial stratification
MeSH terms: Brain Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Female, Humans, Kidney Neoplasms, Lung Neoplasms, Male, Melanoma, Neoplasm Metastasis, Prognosis, Retrospective Studies, Survival Analysis, Neoplasm Grading

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks